Argonaut Expands Lyophilization Facility

Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, is expanding its cGMP facilities in the Greater San Diego area of Carlsbad, CA. This will bring Argonaut’s manufacturing space to over 100,000 square feet and enable Argonaut to accommodate the changing dynamics of its business and the Life Science industry.

The new facility will be equipped with upgrades in additional automation to Argonaut’s existing formulation, fill and finish infrastructure. It will also be home to their new National Lyophilization Center dedicated to solving the ambient stability needs of Point of Care tests globally. This world class site will include additional patented enabling technologies and processes that will lower the cost per device and improve quality and flexibility. Argonaut expects additional facility space to be fully operational this year. Argonaut is committed to bringing point-of-care molecular diagnostics tests to the market faster, better, and more affordably.

“I’m excited that our team and our state-of-the-art facilities are well positioned to respond to the needs of our customers and the increasing demand for our services,” said Wayne Woodard, founder and CEO, Argonaut. “Our expansion will change the landscape and capacity for regulated cGMP lyophilization service, so desperately needed, in the point of care market today and in the future. This expansion in capacity combined with the technology advancements in lyophilization we have made are dramatically advancing our timelines.”